Uta Margareta Demel

5PUBLICATIONS

70CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 12, 2026

Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

|Jan 22, 2026

Aberrant SUMOylation Restricts the Targetable Cancer Immunopeptidome.

Uta M Demel, Anna Meurer, Badeel Kh Q Zaghla

|Oct 20, 2025

Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.

M Korenkov, J Liebaert, S Yousefian

|Feb 20, 2024

Activation of gp130 signaling in T cells drives T<sub>H</sub>17-mediated multi-organ autoimmunity.

Francis Baumgartner, Stefanos A Bamopoulos, Laura Faletti

|Jul 24, 2023

Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs the DNA damage response.

Le Zhang, Matthias Wirth, Upayan Patra

Pageof 1

Frequent Collaborators

Ulrich Keller

Simon Haas

Antonia Busse

M Korenkov

J Liebaert

S Yousefian

S Schwartz

J Braune

N C Görür

C Franke

Frequent Collaborators

Ulrich Keller

Simon Haas

Antonia Busse

M Korenkov